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	 	 Exercise	training	(n=33)	 	 Non-exercise	(n=17)	
	 	 Baseline	 Week	10	 	 Baseline	 Week	10	
Demographics	 	 	 	 	 	 	
Male	gender	(%)	 	 							100	 								-	 	 							100	 									-	
Age	(yrs)	 	 	55.8	±	9.2	 								-	 	 	56.2	±	10.8	 									-	
Height	(m)	 	 			1.7	±	0.1	 								-	 	 			1.8	±	0.1	 									-	
Body	mass	(kg)	 	 	82.7	±	10.2	 83.1	±	10.5	 	 	90.4	±	14.2	 	90.5	±	14.3	
BMI	(kg/m
2
)	 	 	27.4	±	2.6	 27.6	±	2.7	 	 	29.2	±	4.1	 	27.6	±	2.7	
BSA	(m
2
)	 	 			2.0	±	0.1	 		2.0	±	0.1	 	 			2.1	±	0.2	 			2.1	±	0.2	
Clinical	 	 	 	 	 	 	
STEMI	(n)	 	 								20	 								-	 	 								13	 									-	
NSTEMI	(n)	 	 								13	 								-	 	 									4	 									-	
Time	post	MI	(days)	 	 	33.7	±	8.9	 								-	 	 	35.7	±	7.7	 									-	
HRrest	(bpm)	 	 				59	±	8	 			58	±	7	 	 				56	±	7	 				56	±	7	
BPsys	(mmHg)	 	 		113	±	17	 	110	±	16	 	 		118	±	12	 		117	±	12	
BPdia	(mmHg)	 	 				71	±	8	 			71	±	8	 	 				70	±	9	 				70	±	9	
Exercise	test	 	 	 	 	 	 	
VO2	peak	(L.min
-1





)		†	‡	 	 	24.0	±	4.1	§	 27.5	±	4.6****	 	 	20.8	±	3.1	 	20.2	±	4.1	





)	†	‡	 	 	12.5	±	2.8	 14.6	±	3.5****	 	 	11.2	±	1.7	 	10.8	±	2.3	












	 	 Exercise	training	(n=33)	 	 Non-exercise	(n=17)	
	 	 Baseline	 Week	10	 	 Baseline	 Week	10	
LV	size	 	 	 	 	 	 	
LVIDd	(cm)	 	 				4.8	±	0.5	 			4.8	±	0.5	 	 				4.9	±	0.5	 				4.9	±	0.5	
LVIDs	(cm)	 	 				3.2	±	0.5	 			3.3	±	0.5	 	 				3.4	±	0.6	 				3.4	±	0.5	
LVIDd/BSA	(cm/m
2
)	 	 				2.2	±	0.6	 			2.4	±	0.2	 	 				2.4	±	0.6	 				2.4	±	0.2	
LVIDs/BSA	(cm/m
2
)	 	 				1.7	±	0.3	 			1.7	±	0.2	 	 				1.6	±	0.3	 				1.7	±	0.2	
LV	mass	and	geometry	 	 	 	 	 	 	
LV	mass	(g)	 	 			209	±	46	 		217	±	57	 	 			234	±	51	 			217	±	45	
IVSd	(cm)	 	 				1.3	±	0.2	 			1.3	±	0.2	 	 				1.4	±	0.3	 				1.3	±	0.2	
LVPWd	(cm)	 	 				1.1	±	0.2	 			1.1	±	0.2	 	 				1.1	±	0.2	 				1.1	±	0.2	
IVSs	(cm)	 	 				1.7	±	0.2	 			1.7	±	0.2	 	 				1.8	±	0.3	 				1.8	±	0.3	
LVPWs	(cm)	 	 				1.5	±	0.3	 			1.5	±	0.2	 	 				1.5	±	0.3	 				1.5	±	0.3	
RWT	(cm)	 	 		0.45	±	0.08	 	0.45	±	0.08	 	 		0.46	±	0.11	 		0.45	±	0.10	
LV	mass/BSA	(g/m
2













	 	 Exercise	training	(n=33)	 	 Non-exercise	(n=17)	
	 	 Baseline	 Week	10	 	 Baseline	 Week	10	
LV	systolic	function		 	 	 	 	 	 	
Fractional	shortening	(%)	 	 		31.9	±	7.2	 	32.1	±	5.3	 	 		31.9	±	7.2	 		31.5	±	7.3	
Stroke	volume	(ml)	 	 		46.8	±	9.5	 	46.3	±	8.3	 	 		52.9	±	11.9	 		53.1	±	9.8	
Lateral	s’(cm/s)	 	 				8.1	±	2.9	 			8.3	±	2.4	 	 				9.1	±	2.3	 				8.5	±	3.0	
Mean	s’(cm/s)	 	 				8.0	±	1.9	 			8.0	±	1.6	 	 				8.4	±	1.6	 				8.1	±	2.0	
LV	diastolic	function	 	 	 	 	 	 	
E/A	ratio	 	 		1.15	±	0.33	 	1.06	±	0.24	 	 		1.14	±	0.36	 		1.17	±	0.37	
DT	(ms)	 	 			215	±	34	 		224	±	44	 	 			217	±	67	 			245	±	67	
Lateral	e’(cm/s)	 	 				9.5	±	3.3	 	10.0	±	3.1	 	 		10.0	±	3.3	 				9.8	±	2.9	
Lateral	a’(cm/s)	 	 				8.6	±	2.4	 			9.2	±	2.4	 	 				8.9	±	1.4	 				8.8	±	2.3	
Lateral	e’/a’	ratio	 	 				1.2	±	0.5	 			1.1	±	0.4	 	 				1.2	±	0.4	 				1.2	±	0.5	
Lateral	E/e’	ratio	 	 				7.3	±	2.6	 			6.6	±	2.0	 	 				6.6	±	2.0	 				6.2	±	2.8	
Mean	e’(cm/s)	 	 				8.1	±	2.3	 			8.6	±	2.1	 	 				8.9	±	2.4	 				8.8	±	2.1	
Mean	a’(cm/s)	 	 				8.9	±	1.6	 			9.2	±	1.3	 	 				8.9	±	1.2	 				8.6	±	1.9	
Mean	e’/a’	ratio	 	 				1.0	±	0.3	 			1.0	±	0.2	 	 				1.0	±	0.3	 				1.1	±	0.4	
Mean	E/e’	ratio	 	 				8.4	±	2.0	 			7.6	±	1.6	 	 				7.5	±	1.7	 				7.0	±	2.9	
	355	
Data	as	mean	±	SD.	s’,	peak	systolic	mitral	annulus	tissue	velocity;	E/A	ratio,	ratio	of	peak	early	356	
(E)	to	late	(A)	mitral	inflow	velocity;	DT,	rate	of	deceleration	of	early	mitral	inflow;	e’	peak	early	357	
diastolic	mitral	annulus	tissue	velocity;	a’,	peak	late	diastolic	mitral	annulus	tissue	velocity;	e’a’	358	
ratio,	ratio	of	peak	early	to	late	diastolic	mitral	annulus	tissue	velocity;	E/e’	ratio,	ratio	of	peak	359	
early	mitral	inflow	velocity	to	peak	early	diastolic	mitral	annulus	tissue	velocity;	IVRT,	iso-360	
volumic	relaxation	time.	†	P<0.05	time	effect	(ANOVA),	**P<0.01	vs.	baseline.	361	
362	
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